How have treatments for hepatocellular carcinoma improved?
Researchers at the Hospital Clínic-IDIBAPS and the University of Barcelona have published a review article in the journal Nature Cancer in which they1
News about Josep M. Llovet
The role of immunotherapy in hepatocellular carcinoma
Immunotherapy has revolutionized the treatment of hepatocellular carcinoma. Researchers from the Hospital Clínic-IDIBAPS have published a review in t1
A meta-analysis of phase-III trials shows that immunotherapy is more efficacious in liver cancer of viral origin than of nonviral origin
Researchers at IDIBAPS have led a study, published in the journal Gastroenterology, in which they analyzed the clinical trials published in the past1
Molecular map of hepatocellular carcinoma caused by fatty liver disease revealed
IDIBAPS researchers have drafted a molecular map of the most common type of liver cancer, hepatocellular carcinoma, when the origin is fatty liver di1
A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer
An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1
Two articles review current knowledge on the management of hepatocellular carcinoma
Clínic-IDIBAPS researchers have coordinated two review articles on hepatocellular carcinoma (HCC), the most common type of liver cancer, in which the1
Anti-platelet therapy prevents the progression of fatty liver to liver cancer in animal models
A study published in the journal Nature Medicine proposes a paradigm shift in the approach to steatohepatitis, the most advanced degree of non-alcoho1